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Abstract
Objective:  The  potential  role  of  procalcitonin  (PCT)  in  the  diagnosis  of  catheter-related  blood-
stream infection  (CRBSIs)  is  still  unclear  and  requires  further  research.  The  diagnostic  value  of
serum PCT  for  the  diagnosis  of  CRBSI  in  children  is  evaluated  here.
Method:  This  study  was  conducted  between  October  2013  and  November  2014,  and  included
patients  with  suspected  CRBSI  from  1  month  to  18  years  of  age  who  were  febrile,  with  no  focus  of
infection, and  had  a  central  venous  catheter.  Levels  of  PCT  and  other  serum  markers  were  mea-
sured, and  their  utility  as  CRBSI  markers  was  assessed.  Additionally,  the  clinical  performance
of a  new,  automated,  rapid,  and  quantitative  assay  for  the  detection  of  PCT  was  tested.
Results: Among  the  49  patients,  24  were  diagnosed  with  CRBSI.  The  PCT-Kryptor  and  PCT-RTA
values were  signiﬁcantly  higher  in  proven  CRBSI  compared  to  those  in  unproven  CRBSI  (p  =  0.03
and p  =  0.03,  respectively).  There  were  no  differences  in  white  blood  cell  count  and  C-reactive
protein (CRP)  levels  between  proven  CRBSI  and  unproven  CRBSI.  Among  the  24  patients  with
CRBSI, CRP  was  signiﬁcantly  higher  among  those  with  Gram-negative  bacterial  infection  than  in
those with  Gram-positive  bacterial  infections.  PCT-Kryptor  was  also  signiﬁcantly  higher  among
patients  with  Gram-negative  bacterial  infection  than  in  those  with  Gram-positive  bacterial
infections (p  =  0.01  and  p  =  0.02,  respectively).
Conclusions:  The  authors  suggest  that  PCT  could  be  a  helpful  rapid  diagnostic  marker  in  children
with suspected  CRBSIs.
©  2016  Sociedade  Brasileira  de  Pediatria.  Published  by  Elsevier  Editora  Ltda.  This  is  an  open
access article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/
4.0/).
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A  procalcitonina  pode  ser  um  marcador  de  diagnóstico  de  infecc¸ões  de  corrente
sanguínea  relacionadas  a  cateter  em  crianc¸as?
Resumo
Objetivo:  O  possível  papel  da  procalcitonina  (PCT)  no  diagnóstico  de  infecc¸ões  de  corrente
sanguínea  relacionadas  a  cateter  (ICSRCs)  ainda  não  está  claro  e  precisa  ser  mais  pesquisado.
O valor  diagnóstico  da  PCT  sérica  para  o  diagnóstico  de  ICSRC  em  crianc¸as  é  avaliado  neste
estudo.
Método: Este  estudo  foi  feito  entre  outubro  de  2013  e  novembro  de  2014  e  incluiu  pacientes
com suspeita  de  ICSRC  de  um  mês  a  18  anos  de  idade  que  estavam  febris,  não  tinham  foco
de infecc¸ão  e  tinham  cateter  venoso  central.  Foram  medidos  os  níveis  de  PCT  e  de  outros
marcadores  séricos,  cuja  utilidade  como  marcadores  de  ICSRC  foi  avaliada.  Adicionalmente,  foi
testado o  desempenho  clínico  de  um  novo  ensaio  quantitativo  automatizado  e  rápido  para  a
detecc¸ão de  PCT.
Resultados:  Dentre  49  pacientes,  24  foram  diagnosticados  com  ICSRC.  Os  valores  de  PCT-Kryptor
e PCT-RTA  foram  signiﬁcativamente  maiores  em  ICSRCs  comprovadas  do  que  em  ICSRCs  não  com-
provadas (p  =  0,03  e  p  =  0,03,  respectivamente).  Não  houve  diferenc¸a  na  contagem  de  glóbulos
brancos  e  nos  níveis  de  proteína  C  reativa  (PCR)  entre  ICSRCs  comprovadas  e  ICSRCs  não  compro-
vadas. Dentre  os  24  pacientes  com  ICSRC,  a  PCR  era  signiﬁcativamente  maior  entre  aqueles  com
infecc¸ão bacteriana  gram-negativa  do  que  naqueles  com  infecc¸ão  bacteriana  gram-positiva.  O
PCT-Kryptor  também  foi  signiﬁcativamente  maior  entre  pacientes  com  infecc¸ão  por  bactérias
gram-negativas  do  que  naqueles  com  infecc¸ão  por  bactérias  gram-positivas  (p  =  0,01  e  p  =  0,02,
respectivamente).
Conclusões:  Sugerimos  que  a  PCT  pode  ser  um  marcador  de  diagnóstico  rápido  útil  em  crianc¸as
com suspeita  de  ICSRCs.
©  2016  Sociedade  Brasileira  de  Pediatria.  Publicado  por  Elsevier  Editora  Ltda.  Este e´  um  artigo
Open Access  sob  uma  licenc¸a  CC  BY-NC-ND  (http://creativecommons.org/licenses/by-nc-nd/4.
0/).
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Central  venous  catheters  (CVCs)  are  generally  used  to
administer  intravenous  ﬂuids,  medications,  blood  products,
and  parenteral  nutrition  ﬂuids,  to  monitor  hemodynamic
status,  and  to  provide  hemodialysis.1 Catheter-related
bloodstream  infections  (CRBSIs)  are  the  leading  cause  of
nosocomially  acquired  sepsis  including  neonatal  sepsis,2 and
are  associated  with  signiﬁcant  morbidity,  mortality,  and
hospital  costs.1,3 Early  diagnosis  of  CRBSIs  and  appropri-
ate  treatment  may  reduce  the  associated  morbidity  and
mortality.4,5 The  laboratory  criteria  for  diagnosing  CRBSIs
are  precise;  however,  differences  in  the  deﬁnitions  and
methodologies  among  various  studies  have  made  it  difﬁcult
to  compare  the  results.1,6 Conﬁrmation  of  CRBSIs  requires
the  identiﬁcation  of  microorganisms  recovered  from  blood
and  catheter  tips.  Although  blood  culture  is  the  best  method
for  the  diagnosis  of  bloodstream  infections,  test  results
are  not  rapidly  available.  Additionally,  only  15--25%  of  the
CVC  tips  that  reach  the  microbiology  laboratory  turn  out
to  be  culture-positive.  Furthermore,  not  all  CRBSIs  require
the  catheter  to  be  withdrawn.7,8 Therefore,  the  diagnosis
of  CRBSIs  by  conservative  methods  (without  catheter  with-
drawal)  appears  to  be  more  reasonable  in  clinical  settings
to  avoid  unnecessary  removal  of  the  vascular  catheter  and
antibiotic  overuse.9
Since  the  removal  of  such  devices  is  often  a  challenge,
true  CRBSI  should  be  conﬁrmed  to  distinguish  it  from  con-
taminated  blood  cultures,  catheter  colonization  without
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moncomitant  bloodstream  infection,  or  fever  from  another
ource.  Various  methods  have  been  previously  used  to  diag-
ose  CRBSI  without  catheter  removal.1 Early  and  established
iomarkers  may  be  useful  for  diagnosis,  prognosis,  and  mon-
toring  of  response  to  therapy.10 Commonly  used  biomarkers
uch  as  white  blood  cells  (WBCs)  or  C-reactive  protein
CRP)  lack  adequate  speciﬁcity  for  the  diagnosis  of  bac-
erial  infections.9 Serum  procalcitonin  (PCT),  a  116-amino
cid  polypeptide,  has  recently  emerged  as  a  biomarker  for
he  diagnosis  of  various  bacterial  infections.  It  was  found
o  have  a  higher  diagnostic  accuracy  when  compared  with
ther  commonly  used  laboratory  parameters,  such  as  WBC
nd  CRP.11--13 PCT  levels  are  found  to  be  lower  in  the  serum
f  healthy  humans,  but  are  signiﬁcantly  elevated  in  those
uffering  from  severe  infections,  particularly  sepsis.14,15 To
he  best  of  the  author’s  knowledge,  only  a  few  studies  have
ssessed  the  rationale  behind  PCT  levels  for  the  accurate
iagnosis  of  CRBSIs,16,17 especially  in  children.
Thus,  the  present  study  aimed  to  evaluate  the  accuracy
f  PCT  for  the  diagnosis  of  CRBSIs  in  children.  Furthermore,
he  clinical  performance  of  a  new,  automated,  and  rapid
uantitative  assay  was  also  examined.
aterials and methodshis  study  was  conducted  between  October  2013  and
ovember  2014  on  patients  with  clinical  suspicion  of  CRBSI
nd  eligible  for  inclusion.  Patients  who  were  aged  between  1
onth  and  18  years,  febrile,  with  no  focus  of  infection,  and
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ad  a  central  venous  catheter  were  enrolled  in  the  study.
he  investigation  was  reviewed  and  approved  by  the  ethi-
al  committee  of  the  Zekai  Tahir  Burak  Maternity  Teaching
ospital,  Ministry  of  Health,  Ankara,  Turkey.
Clinical  suspicion  of  CRBSI  was  based  on  the  onset  of
he  following  features  suggestive  of  infection:  (a)  clinical
anifestations  of  infection  (fever,  chills,  and/or  hypoten-
ion);  (b)  use  of  central  venous  catheter  for  over  48  h;  and
c)  no  other  apparent  source  of  infection.1 In  cased  of  sus-
ected  CRBSI,  paired  blood  samples  from  the  catheter  and
 peripheral  vein  were  obtained  and  submitted  for  culture
est.1
According  to  previously  published  guidelines,  a  deﬁni-
ive  diagnosis  of  CRBSI  requires  either  the  isolation  of  the
ame  organism  from  the  peripheral  blood  culture  and  the
ulture  of  the  catheter  tip  or  positive  culture  from  both  the
atheter  hub  and  blood  from  peripheral  vein,  meeting  the
RBSI  criteria.1,16
Patients  with  any  active  infection  other  than  CRBSI  or
hose  who  showed  culture  negativity  despite  the  suspicion
f  CRBSI  were  excluded  from  the  study  (13  patients).  If  a
atient  had  more  than  one  episode  of  suspected  CRBSI  during
he  study  period,  only  the  ﬁrst  episode  was  included.
For  monitoring  purposes,  patients  with  proven  CRBSI
ere  categorized  into  two  subgroups  depending  on  the
nfection  control:  (a)  controlled,  patients  with  controlled
nfection  (n  =  20),  deﬁned  as  clinical  and  microbiological
mprovement,  and  (b)  not  controlled,  patients  with  uncon-
rolled  infection  (n  =  4),  deﬁned  as  persistent  bacteremia
the  same  pathogen  responsible  for  the  ﬁrst  episode  was
ultured  72  h  after  catheter  removal  or  72  h  after  initia-
ion  of  the  appropriate  treatment),  superinfection  (CRBSI
ue  to  another  pathogen  during  the  therapy  period),  or
eath  related  to  CRBSI.16 Mortality  was  deﬁned  as  related
o  CRBSI  if  death  occurred  within  the  ﬁrst  28  days  of  CRBSI
uspicion.
Blood  samples  were  assessed  for  routine  hematology
nd  biochemistry  panels,  as  well  as  for  PCT  and  CRP  lev-
ls.  PCT  levels  were  determined  using  Brahms  Kryptor®
ompact  immunoassay  analyzer  (Thermoﬁsher,  Hennigsdorf,
ermany)  and  RTA® Procalcitonin  device  (RTA,  Kocaeli,
urkey)  simultaneously.  Both  assays  required  a  minimum
f  80  L  serum,  and  tested  positive  if  PCT  levels  were
reater  than  0.5  ng/mL,  according  to  the  manufacturer’s
nstructions.  Preferably,  fresh  serum  samples  were  used  for
easurements.  However,  if  samples  were  not  used  on  the
ame  day,  they  were  frozen  at  −20 ◦C.
tatistical  analysis
ata  were  analyzed  using  the  SPSS  version  19.0  (SPSS,
nc.  --  Chicago,  USA).  Descriptive  statistics  were  used
o  summarize  the  participants’  baseline  characteristics,
ncluding  means,  standard  deviations  (SDs),  medians,  and
nterquartile  ranges  for  continuous  variables  and  frequency
istributions  for  categorical  variables.  To  compare  the  base-
ine  characteristics  according  to  the  occurrence  of  CRBSI,
he  2 test  was  used  for  categorical  variables.  The  normality
f  quantitative  variables  was  tested  by  Kolmogorov--Smirnov
est.  For  continuous  variables,  the  independent-groups  t
est  was  used  for  normally  distributed  variables  or  the
t
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onparametric  Mann--Whitney  U  test,  if  the  normality
ssumption  was  violated.  The  area  under  the  receiver  oper-
ting  characteristic  (ROC)  curve  was  calculated  to  evaluate
he  diagnostic  and  prognostic  signiﬁcance  of  the  tested
arameters.  Data  were  expressed  as  area  under  ROC  curves
ith  95%  conﬁdence  intervals  (CIs).  The  Youden  index  (max-
mum  level  of  sensitivity  +  maximum  level  of  speciﬁcity)
as  used  to  ﬁnd  the  optimal  cut-off  points.  The  sensitiv-
ty,  speciﬁcity,  positive  predictive  value  (PPV),  and  negative
redictive  value  (NPV)  were  also  calculated.  The  agree-
ents  of  the  PCT  values  between  the  two  PCT  devices
ere  determined  by  Cohen’s    coefﬁcient.  In  all  analyses,
wo-tailed  p-values  <0.05  were  regarded  as  statistically  sig-
iﬁcant.
esults
haracteristics  of  the  study  population
linical  suspicion  of  CRBSI  was  noted  in  62  children.  These
ubjects  did  not  show  an  obvious  alternative  source  for
nfection.  Microbiological  culture  of  urine  and  chest  X-ray
ere  negative.  Thirteen  children  with  infection  other  than
RBSI  during  hospitalization  were  excluded  from  the  study.
f  the  remaining  49  patients,  25  (51%)  were  proven  as  not
uffering  from  CRBSI  (unproven  CRBSI)  and  24  (49%)  were
ositive  for  CRBSI  (proven  CRBSI).
The  demographic  and  clinical  characteristics  of  the
atients  are  summarized  in  Table  1. During  the  study
eriod,  49  patients  (34.7%  female,  n  =  17;  65.3%  male,
 =  32)  from  the  240  beds  at  the  Pediatric  Unit  of  Uni-
ersity  Hospital,  Ankara,  Turkey,  were  enrolled,  with  a
ean  age  of  72.8  ±  66.9  months  (range:  2--252  months).
o  statistically  signiﬁcant  differences  were  found  regarding
atients’  age  (p  =  0.24)  and  gender  (p  =  0.14;  Table  1).  The
ccompanying  co-morbidities  were  as  follows:  25  (52%)
atients  had  non-oncologic  diagnosis,  including  chronic
iarrhea,  cholestasis,  renal  failure,  neurologic  diseases
equiring  continuous  total  parenteral  nutrition,  while  the
emaining  24  (48%)  patients  had  hematologic  or  onco-
ogic  malignancies/diseases,  including  acute  lymphoblastic
eukemia,  acute  myelogenous  leukemia,  or  central  nervous
ystem  tumors  (e.g., ependymoma,  primitive  neuroectoder-
al  tumor;  Table  1).
Among  the  24  patients  with  proven  CRBSI,  12  (50%)  had
ram-positive  bacteriemia,  ten  (41.7%)  had  Gram-negative
acteriemia,  and  two  (8.3%)  presented  candidemia.  The
icroorganisms  considered  responsible  for  CRBSI  were
taphylococcus  epidermidis  (n  =  7),  Klebsiella  pneumo-
iae  (n  = 4),  Escherichia  coli  (n  =  3),  Staphylococcus  aureus
n  = 2),  Staphylococcus  haemolyticus  (n  =  2),  Pseudomonas
eruginosa  (n  =  1),  Klebsiella  oxytoca  (n  =  1),  Acinetobac-
er  baumannii  (n  =  1),  Enterococcus  faecalis  (n  =  1),  Candida
arapsilosis  (n  =  1),  and  Candida  lusiteniae  (n  =  1).  The  group
f  patients  with  uncontrolled  infection  included  one  patient
ith  persistent  bacteremia,  one  patient  with  superinfec-
ion,  and  two  patients  who  died  due  to  CRBSI.  The  isolated
athogens  from  patients  with  uncontrolled  infection  were
ram-negative  organisms,  including  E.  coli  (n  =  1)  and  K.
xytoca  (n  =  1;  responsible  for  death),  and  Gram-positive
Catheter-related  blood  stream  infection  and  procalcitonin  417
Table  1  Patients’  demographics  and  clinical  characteristics.
Proven  CRBSI  (n  =  24)  Not  proven  CRBSI  (n  =  25)  p
Age  [month;  mean  ±  SD  (Min.--Max.)]  67.2  ±  71.7  (3.0--252.0)  78.2  ±  63.1  (2.0--245.0)  0.24a
Gender  0.14b
Female  [n  (%)]  11  (45.8)  6  (24)
Male [n  (%)]  13  (54.2)  19  (76)
Primary admission  diagnosis  0.39b
Hematological  [n  (%)]  12  (50)  15  (60)
Nephrological  [n  (%)]  4  (16.7)  1  (4.0)
Immunological  [n  (%)]  2  (8.3)  2  (8.0)
Gastroenterological  [n  (%)]  3  (12.5)  1  (4.0)
Other [n  (%)] 3  (12.5) 6  (24.0)
WBC count  [103/L;  median  (IQR)] 5.20  (0.9--13.0) 1.7  (0.8--5.4) 0.17c
Platelet  [103/L;  median  (IQR)]  118.0  (43.0--237.2)  111.0  (22.0  --214.5)  0.83c
CRP  [mg/dL;  median  (IQR)]  5.63  (1.17--12.45)  2.10  (0.73--8.5)  0.33c
PCT-Kryptor  [ng/mL;  median  (IQR)]  1.77  (0.30--4.96)  0.28  (0.17--0.68)  0.03c,d
PCT-RTA  [ng/mL;  median  (IQR)]  1.76  (0.71--3.13)  0.57  (0.26--1.00)  0.03c,d
Mortality  [n  (%)] 2  (8.3)  0  (0)  N/A
WBC, white blood cell; CRP, C-reactive protein; PCT, procalcitonin; IQR, interquartile range; CRBSI, catheter-related blood stream
infection; N/A, not applicable; SD, standard deviation.
a Student’s t test.
b Chi-squared test.
c Mann--Whitney test.
d Statistically signiﬁcant difference.
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eorganisms,  which  included  S.  epidermidis  (n  =  1)  and  S.
aureus  (n  =  1).
PCT-Kryptor  and  PCT-RTA  values  were  signiﬁcantly  higher
in  patients  with  proven  CRBSI  when  compared  with  those  in
patients  with  unproven  CRBSI  (p  =  0.03  and  p  =  0.03,  respec-
tively).  CRBSI  patients  did  not  show  a  signiﬁcant  increase
in  CRP  values,  as  compared  to  non-CRBSI  patients  (p  =  0.33;
Table  1).  The  distribution  of  PCT  and  CRP  values  according  to
the  patient  group  is  shown  in  Fig.  1.  Among  the  24  patients
with  CRBSI,  CRP  was  signiﬁcantly  higher  among  patients
with  Gram-negative  bacterial  infection  (12.30  [5.65--32.57])
than  in  those  with  Gram-positive  bacterial  infection  (2.33
[0.40--9.15],  p  =  0.01).  PCT-Kryptor  was  also  signiﬁcantly
higher  among  patients  with  Gram-negative  bacterial  infec-
tion  (4.40  [1.69--19.22])  than  in  those  with  Gram-positive
bacterial  infections  (0.32  [0.08--2.10],  p  =  0.02).  Among  the
24  patients  with  CRBSI,  those  with  uncontrolled  infection
did  not  show  signiﬁcant  increases  in  PCT-Kryptor,  PCT-RTA,
and  CRP  values,  when  compared  with  patients  with  con-
trolled  infection  (p  =  0.91,  0.48,  and  0.14,  respectively).
The  agreement  of  the  PCT  values  between  PCT-Kryptor
and  PCT-RTA  devices  was  considered  as  intermediate
(:  0.548).
The  areas  under  the  ROC  curves  for  the  diagnosis  of
CRBSI  were  0.684  (95%  CI,  0.526--0.843;  p  =  0.03)  for  PCT-RTA
(best  cutoff,  1.18  ng/mL)  and  0.683  (95%  CI,  0.525--0.842;
p  =  0.03)  for  PCT-Kryptor  (best  cutoff,  0.86  ng/mL;  Fig.  2).
The  area  under  the  ROC  curves  for  the  diagnosis  of  CRBSI
was  0.581  (95%  CI,  0.417--0.745;  p  =  0.33)  for  CRP.  The  sen-
sitivity,  speciﬁcity,  PPV,  NPV,  and  accuracy  of  PCT-RTA  were
0.71,  0.80,  0.77,  0.74,  and  0.75,  respectively.  The  sensitiv-
ity,  speciﬁcity,  PPV,  NPV,  and  accuracy  of  PCT-Kryptor  were
0.66,  0.84,  0.80,  0.72,  and  0.75,  respectively.
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urrent  methods  for  the  diagnosis  of  CRBSIs  are  time-
onsuming  and  rely  on  culture  techniques  that  require
4--48  h to  conﬁrm  the  diagnosis.  Therefore,  parameters
hat  accurately  distinguish  CRBSI  from  non-CRBSI  at  an  early
tage  are  important.17 In  the  present  study,  PCT  was  consid-
red  a  good  diagnostic  marker  when  compared  with  WBC  and
RP.  PCT  can  distinguish  patients  with  CRBSI  from  patients
ith  BSI  from  other  sources.  Additionally,  on  the  day  of  clin-
cal  suspicion  of  the  infection,  a  cutoff  point  of  0.86  ng/mL
f  PCT  was  shown  to  distinguish  patients  with  and  without
RBSI.  The  speciﬁcity  of  the  test  was  0.84  and  a  positive
esult  in  any  patient  may  be  used  as  a  parameter  to  remove
entral  lines  immediately.  The  RTA-PCT  assay  showed  mod-
rate  concordance  with  the  established  Kryptor  method,
ith  an  optimal  cutoff  of  1.18  ng/mL.  Therefore,  this  tech-
ique  can  be  considered  as  a  useful  tool  in  various  medical
ettings,  although  it  requires  further  evaluation  in  larger
tudies.
The  present  ﬁndings  are  in  agreement  with  some  of  the
ecent  reports  that  assessed  the  diagnostic  value  of  PCT  for
arly  detection  of  different  infections  in  the  intensive  care
nit  (ICU).16,18,19 The  diagnostic  value  of  PCT  in  CRBSIs  was
lso  evaluated  in  a  different  cohort,  and  the  present  ﬁndings
re  consistent  with  those  reports.16,17 However,  the  authors
n  those  reports  did  not  speciﬁcally  evaluate  CRBSI  in  chil-
ren,  and  a  proportion  of  their  patients  had  suffered  septic
pisodes.Biomarkers  of  inﬂammation,  such  as  the  WBC  count
nd  CRP  levels,  can  also  be  evaluated  to  diagnose  CRB-
Is,  although  their  speciﬁcity  is  lower.20 Several  studies
ave  reported  the  clinical  value  of  CRP  in  the  diagnosis
418  Ozsurekci  Y  et  al.
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14,21--23f  bacterial  infections,  especially  sepsis. Addition-
lly,  Theodorou  et  al.16 have  reported  that  the  diagnostic
ccuracy  of  PCT  in  patients  with  CRBSIs  is  signiﬁcantly
igher  when  compared  with  WBC  and  CRP.  Consistent  with
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an  (CRP)  according  to  the  study  groups.  CRBSI,  catheter-related
his  report,  we  have  not  observed  signiﬁcant  differences
n  the  CRP  levels  between  patients  with  and  without
RBSI.
In  order  of  prevalence,  the  four  groups  of  microbes  that
ost  commonly  cause  CRBSI  associated  with  percutaneous
nsertion  are  coagulase-negative  staphylococci,  S.  aureus,
andida  species,  and  enteric  Gram-negative  bacilli.1 Con-
istent  with  that  report,1 the  dominant  causative  agent  of
RBSI  in  the  present  study  was  coagulase-negative  staphylo-
occi.  However,  contrary  to  the  present  ﬁndings,  Theodorou
t  al.16 have  reported  that  Gram-negative  bacteria  were
redominantly  recovered  from  patients  with  proven  CRBSI,
nd  their  patients  were  critically  ill  with  prolonged  inten-
ive  care  unit  stay.  Consistent  with  the  ﬁndings  by  Chen
t  al.,17 the  present  ﬁndings  also  underlined  that  the  PCT
oncentrations  and  CRP  levels  were  higher  among  patients
ith  Gram-negative  bacteremia  than  among  those  with
ram-positive  bacterial  infections.  Dandona  et  al.24 and
inscheid  et  al.25 have  described  that  serum  PCT  levels
ay  be  markedly  increased  by  endotoxins  (lipopolysaccha-
ides),  and  the  present  ﬁnding  may  possibly  be  explained  by
uch  stimulations.  Additionally,  most  of  the  Gram-positive
acterial  infections  in  the  present  study  were  caused  by
oagulase-negative  staphylococci,  which  is  a  less  virulent
rganism  than  any  of  the  listed  Gram-negatives.  Therefore,
he  determination  of  the  NPV  of  the  test  will  probably  be
ore  signiﬁcant  than  the  PPV  to  start  on  antimicrobial  ther-
py  empirically.
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1Catheter-related  blood  stream  infection  and  procalcitonin  
Several  ICU  cases  can  be  empirically  managed  with-
out  immediate  catheter  withdrawal.  On  many  occasions,
watchful  waiting  is  a  prudent  approach.26 Some  CRBSIs  in
hemodynamically  stable  patients  can  be  handled  in  situ
by  using  antibiotics,  and  frequently,  bacteremia  is  cleared
and  the  catheter  is  sterilized.8,27 In  20  of  the  24  patients
with  CRBSI  in  the  present  study,  bacteremia  was  cleared
and  the  catheter  was  sterilized  with  accurate  antimicro-
bials,  without  removal.  This  result  was  especially  important
for  children,  considering  the  underlying  reasons,  including
malignancies,  in  the  present  study.  However,  Gram-negative
bacteria  were  recovered  from  two  of  the  deceased  children.
When  the  patients  were  considered  as  controlled  and  not
controlled  for  infection  in  the  present  study,  although  PCT
or  WBC  and  CRP  were  not  the  discriminating  biomarkers,  the
PCT  results  may  have  provided  the  earliest  opportunity  to
remove  a  catheter  while  awaiting  the  blood  culture  results.
Some  limitations  of  the  present  study  should  also  be
noted  here.  First,  the  sample  population  was  relatively
smaller  and  heterogeneous  regarding  the  underlying  dis-
ease  conditions.  Therefore,  the  present  results  need  to  be
conﬁrmed  in  a  larger  and  more  homogeneous  pool.  A  con-
trol  group  was  not  designed  in  this  study,  but  rather  two
groups  including  proven  CRBSI  and  unproven  CRBSI  from
the  population  of  children  with  central  lines  were  catego-
rized  at  the  end  of  the  study  period  to  create  the  desired
groups.  Conversely,  a  control  population  with  blood  stream
infection  from  children  without  central  lines  that  are  not
catheter  related  may  allow  for  a  better  understanding  of
other  catheter-related  blood  stream  infections.  However,
the  present  results  are  very  important,  due  to  the  scarcity
of  studies  on  early  CRBSI  diagnosis  in  children.  In  addition,
patients  who  had  any  other  infection  were  excluded,  and
the  withdrawal  of  potential  confounders  may  increase  the
strength  of  the  present  ﬁndings  about  biomarkers  as  diag-
nostic  and  monitoring  tools.  Second,  it  was  not  possible  to
perform  the  sequential  analysis  of  the  infectious  biomarkers
to  understand  the  longitudinal  changes  in  the  PCT  concen-
tration  and  optimal  timing  of  the  PCT  for  prognostic  value,
due  to  ﬁnancial  constraints.
In  conclusion,  PCT  may  be  a  useful  rapid  diagnos-
tic  biomarker  for  suspected  CRBSI  in  children.  The  new
automated  rapid  quantitative  assay,  the  PCT-RTA  (Kocaeli,
Turkey),  has  some  beneﬁts  such  as  small  size,  easy
implantability  in  a  laboratory,  and  ease  of  interpretation
of  the  results  for  the  measurement  of  PCT  values.  This
assay,  with  a  sensitivity  and  speciﬁcity  of  71%  and  80%,
respectively,  is  an  immunochromatographic  test  for  the
quantitative  detection  of  PCT,  and  is  easy  to  use  under  emer-
gency  conditions.
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